Type-1 cannabinoid receptor (CB1R) are crucial regulators of both excitatory and inhibitory synaptic transmission in different brain areas [11, 12], including the striatum [13, 14] and the brain area involved in MS [15]. The gene discussed is CNR1; the disease is myeloid sarcoma.